DK155085A - Interleukinholdige liposomer - Google Patents

Interleukinholdige liposomer Download PDF

Info

Publication number
DK155085A
DK155085A DK155085A DK155085A DK155085A DK 155085 A DK155085 A DK 155085A DK 155085 A DK155085 A DK 155085A DK 155085 A DK155085 A DK 155085A DK 155085 A DK155085 A DK 155085A
Authority
DK
Denmark
Prior art keywords
interleuk
containing liposomes
liposomes
interleuk containing
Prior art date
Application number
DK155085A
Other languages
English (en)
Other versions
DK155085D0 (da
Inventor
Thomas Kissel
Joerg Reinhardt
Henriette Schrank
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848409127A external-priority patent/GB8409127D0/en
Priority claimed from GB848409128A external-priority patent/GB8409128D0/en
Priority claimed from GB848409126A external-priority patent/GB8409126D0/en
Priority claimed from GB848409125A external-priority patent/GB8409125D0/en
Priority claimed from GB848420381A external-priority patent/GB8420381D0/en
Priority claimed from GB848423700A external-priority patent/GB8423700D0/en
Priority claimed from GB848423701A external-priority patent/GB8423701D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK155085D0 publication Critical patent/DK155085D0/da
Publication of DK155085A publication Critical patent/DK155085A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK155085A 1984-04-09 1985-04-03 Interleukinholdige liposomer DK155085A (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB848409127A GB8409127D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409128A GB8409128D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409126A GB8409126D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409125A GB8409125D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848420381A GB8420381D0 (en) 1984-08-10 1984-08-10 Interleukin therapy
GB848423700A GB8423700D0 (en) 1984-09-19 1984-09-19 Interleukin therapy
GB848423701A GB8423701D0 (en) 1984-09-19 1984-09-19 Interleukin therapy

Publications (2)

Publication Number Publication Date
DK155085D0 DK155085D0 (da) 1985-04-03
DK155085A true DK155085A (da) 1985-10-10

Family

ID=27562708

Family Applications (1)

Application Number Title Priority Date Filing Date
DK155085A DK155085A (da) 1984-04-09 1985-04-03 Interleukinholdige liposomer

Country Status (13)

Country Link
US (1) US4863740A (da)
JP (1) JPH0665650B2 (da)
AU (1) AU4094685A (da)
CH (1) CH668554A5 (da)
DE (1) DE3512926A1 (da)
DK (1) DK155085A (da)
FR (1) FR2562421B1 (da)
GB (1) GB2157172B (da)
IL (1) IL74835A0 (da)
IT (1) IT1199967B (da)
LU (1) LU85839A1 (da)
NL (1) NL8501010A (da)
SE (1) SE8501709L (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
DE3682257D1 (de) * 1985-11-22 1991-12-05 Takeda Chemical Industries Ltd Liposomzusammensetzung.
EP0274219A3 (en) * 1986-12-04 1988-08-03 Takeda Chemical Industries, Ltd. Interleukin-2-containing liposome composition and method for the production thereof
FR2624741B1 (fr) * 1987-12-21 1991-06-28 Pasteur Institut Compositions a base d'une combinaison de liposomes et de lymphokine presentant des proprietes immunostimulantes et leurs applications en medecine humaine et veterinaire
US5258499A (en) * 1988-05-16 1993-11-02 Vestar, Inc. Liposome targeting using receptor specific ligands
JPH03505576A (ja) * 1988-05-16 1991-12-05 ネクスター・フアーマシユーテイカルズ・インコーポレイテツド 有機化合物に関する改良
EP0577146A3 (en) * 1988-05-16 1994-02-02 NeXstar Pharmaceuticals, Inc. Liposomes coupled to hormones
DE68927679T2 (de) * 1988-10-27 1997-06-26 Univ Minnesota Immunhilfsmittel aus Liposome enthaltend Lymphokin IL -2
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
EP0478715B1 (en) * 1989-06-23 1996-04-03 The Liposome Company, Inc. Targeted liposomes and methods for liposome-protein coupling
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5817333A (en) * 1991-10-31 1998-10-06 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation containing a tricyclic compound
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
US5229109A (en) * 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US5449663A (en) * 1993-06-11 1995-09-12 Bicher; Haim I. Antineoplastic compositions
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6406689B1 (en) 1995-10-03 2002-06-18 Frank W. Falkenberg Compositions and methods for treatment of tumors and metastatic diseases
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
WO1998052581A1 (en) 1997-05-20 1998-11-26 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
AU756139B2 (en) * 1997-12-01 2003-01-02 Fang Fang Multivalent recombinant antibodies for treating HRV infections
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
EP1045688A1 (en) * 1998-01-16 2000-10-25 Biomira Usa Inc. Lipomatrix preparation
AU759641B2 (en) 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
CN102151337B (zh) 2000-03-13 2014-03-12 恩根尼公司 调节消化道蛋白表达的组合物和方法
US20040102388A1 (en) * 2000-03-22 2004-05-27 High Katherine A. Modified blood clotting factors and methods of use
CA2898314A1 (en) 2001-07-19 2003-07-31 Perian Therapeutics, Inc. Multimeric proteins and methods of making and using same
US20030044354A1 (en) * 2001-08-16 2003-03-06 Carpenter Alan P. Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
TWI461436B (zh) 2005-11-25 2014-11-21 Kyowa Hakko Kirin Co Ltd 人類ｃｄ１３４（ｏｘ４０）之人類單株抗體及其製造及使用方法
EP1795540A1 (en) 2005-11-30 2007-06-13 Imaxio Multimeric complexes of antigens and an adjuvant
AU2007243442A1 (en) * 2006-04-24 2007-11-08 Shantha West, Inc. AgRM2 antigen
US20080199475A1 (en) 2006-11-27 2008-08-21 Patrys Limited Novel glycosylated peptide target in neoplastic cells
US8647623B2 (en) 2009-04-10 2014-02-11 Kyowa Hakko Kirin Co., Ltd Method for treatment of blood tumor using anti-TIM-3 antibody
HUE025966T2 (en) 2009-04-27 2016-05-30 Kyowa Hakko Kirin Co Ltd Anti-IL-3RA antibody for use in the treatment of blood cancer
US9556272B2 (en) 2009-11-11 2017-01-31 The Trustees Of The University Of Pennsylvania Anti-TEM1 antibodies and uses thereof
WO2013162748A1 (en) 2012-04-27 2013-10-31 The Trustees Of The University Of Pennsylvania Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
JP2016514091A (ja) 2013-02-08 2016-05-19 ミスフォールディング ダイアグノスティクス， インコーポレイテッド トランスサイレチン抗体およびその使用
EP3013945B1 (en) 2013-06-25 2020-05-27 Temple University Of The Commonwealth System Of Higher Education Cortical bone-derived stem cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1578776A (en) * 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
WO1983003383A1 (en) * 1982-03-29 1983-10-13 Liposome Co Inc Stable plurilamellar vesicles
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
EP0109861A3 (en) * 1982-11-23 1986-05-14 Bio-Response Inc. Method for isolating cells
WO1985000606A1 (en) * 1983-07-19 1985-02-14 Takeda Chemical Industries, Ltd. Human il-2 and process for its preparation
US4464461A (en) * 1983-07-22 1984-08-07 Eastman Kodak Company Development of light-sensitive quinone diazide compositions
US4764359A (en) * 1984-05-25 1988-08-16 Lemelson Jerome H Drug compositions and their use in treating human or other mammalian patients
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids

Also Published As

Publication number Publication date
NL8501010A (nl) 1985-11-01
JPS60243022A (ja) 1985-12-03
FR2562421A1 (fr) 1985-10-11
SE8501709D0 (sv) 1985-04-04
DE3512926A1 (de) 1985-10-24
IT8547939A1 (it) 1986-10-09
LU85839A1 (fr) 1985-12-16
SE8501709L (sv) 1985-10-10
CH668554A5 (de) 1989-01-13
IT1199967B (it) 1989-01-05
IT8547939A0 (it) 1985-04-09
GB2157172B (en) 1988-12-29
US4863740A (en) 1989-09-05
IL74835A0 (en) 1985-07-31
GB2157172A (en) 1985-10-23
DK155085D0 (da) 1985-04-03
FR2562421B1 (fr) 1989-02-17
JPH0665650B2 (ja) 1994-08-24
AU4094685A (en) 1985-10-17
GB8508809D0 (en) 1985-05-09

Similar Documents

Publication Publication Date Title
DK155085D0 (da) Interleukinholdige liposomer
DK573585A (da) Steoride liposomer
AT380762B (de) Hoergeraet
AT379929B (de) Hoergeraet
ATA98284A (de) Schalplatte
ATA135485A (de) Maishaecksler
FR2563962B3 (fr) Interceps perfectionne
AT386724B (de) Haecksler
DE3564103D1 (de) Novel alpha-aminoalkyl-alpha-alkylphenylacetonitriles
ATA237384A (de) Maehwerk
DK231185D0 (da) Tuftingnaal
ATA187784A (de) Vulkanisierform
DK98585D0 (da) Des-prolinvasopressin-antagonister
ATA45484A (de) Kimme
AT389296B (de) Elektrokoagulator
DK138585D0 (da) Vaskemiddel
ES278178Y (es) Cuelga-escobas mejorado
KR860003635U (ko) 개량 가통보
RO91310A2 (ro) Solutie oftalmica tamponata
AR231237A1 (es) Calzado-patin
BR8400889A (pt) Palletizador-despalletizador
BR6401828U (pt) Panquequeira
BR6401784U (pt) Trimino
BR6401746U (pt) Televisor
BR6401644U (pt) Aduela balanco

Legal Events

Date Code Title Description
PUP Patent expired